Literature DB >> 10459627

HBeAg immunostaining of liver tissue in various stages of chronic hepatitis B.

M Lindh1, K Savage, J Rees, L Garwood, P Horal, G Norkrans, A P Dhillon.   

Abstract

AIMS: We studied the tissue expression of hepatitis B e antigen (HBeAg) in 29 liver biopsies from 27 HBV carriers.
METHODS: HBeAg expression was assessed in relation to HBeAg in serum, precore mutations, HBV DNA levels and liver damage as measured by histology activity index.
RESULTS: HBeAg in liver tissue was detected by immunostaining in 6 of 7 patients positive for HBeAg in serum. In patients negative for HBeAg in serum, HBeAg was detected in none of 11 specimens from patients infected exclusively with a precore mutant that disrupts HBeAg synthesis, as compared with 3 of 11 specimens from patients carrying HBV with an intact precore region. These 3 patients all showed high HBV DNA levels in serum and severe liver damage.
CONCLUSIONS: Overall, viral replication was strongly associated with the cytoplasmic HBeAg and nuclear HBcAg staining, but not with tissue staining for HBsAg. Because of the close relationship between tissue HBeAg expression and high viral load, the pathogenetic importance of HBeAg remains unclear.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10459627     DOI: 10.1111/j.1478-3231.1999.tb00052.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  3 in total

1.  In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infection.

Authors:  Liza M Cabuang; Tim Shaw; Margaret Littlejohn; Danni Colledge; Vitini Sozzi; Sally Soppe; Nadia Warner; Alex Thompson; Scott Preiss; Natasha Lam; Renae Walsh; Sharon R Lewin; Chloe L Thio; Gail Matthews; Stephen A Locarnini; Peter A Revill
Journal:  J Med Virol       Date:  2012-08       Impact factor: 2.327

2.  Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment.

Authors:  Hong-Lei Han; Zhen-Wei Lang
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

3.  Addition of nucleoside analogues to peg-IFNα-2a enhances virological response in chronic hepatitis B patients without early response to peg-IFNα-2a: a randomized controlled trial.

Authors:  Yan Xu; Xu Wang; Zhenhua Liu; Changyu Zhou; Wenqian Qi; Jian Jiao; Fan Yu; Honghua Guo; Ping Zhao; Jiangbin Wang
Journal:  BMC Gastroenterol       Date:  2017-08-30       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.